In a research note released yesterday, Roth Capital analyst Joseph Pantginis maintained coverage with a Buy rating on shares of Cytori Therapeutics (CYTX), and a price target of $10, following yesterday’s …
In a research report released yesterday, Roth Capital analyst Ed Arce reiterated a Buy rating on AcelRx Pharmaceuticals Inc. (ACRX) with a price …
In a research note issued today, Roth Capital analyst Anton Brenner maintained a Buy rating on Landec Corporation (LNDC) with a price target …
In a research note issued this morning, Roth Capital analyst Scott Henry maintained a Buy rating on RedHill Biopharma (RDHL) and raised his price target …
In a research report released this morning, Roth Capital analyst Debjit Chattopadhyay initiated coverage on shares of PTC Therapeutics (PTCT). He issued a Buy …
Roth Capital, lead by analyst Philip Shen, is hosting two days of booth tours at the 2014 Intersolar North America conference on July …
In a research note released this morning, Roth Capital analyst Scott Henry maintained a Buy rating on BioDelivery Sciences (BDSI) and raised his price target …
In a research note released Wednesday, Roth Capital analyst Jeff Martin reiterated coverage on Franklin Covey (FC) with a Buy rating and a $27.00 price target, following 3Q14 earning results.
In a report released this morning, Roth Capital analyst Debjit Chattopadhyay reiterated coverage on MacroGenics, Inc. (MGNX) with a Buy rating and a $30.
In a report released Tuesday, Roth Capital analyst Debjit Chattopadhyay reiterated coverage on CTI BioPharma Corp (CTIC) with a Buy rating and a $4.00 price target, following yesterday’s news …
